1. ZOLL Medical (ZOLL) designs and markets medical devices and software solutions for emergency medical service providers.
Analysts polled by Bloomberg expect the company to report earnings of 16 cents per share for the first quarter of fiscal year 2011 ended Dec. 31, 2010, in comparison to earnings of 11 cents per share in the year-ago period. Analysts estimate the company to report earnings of $1.16 per share for fiscal 2011 and $1.76 per share for fiscal 2012, a significant improvement from earnings of 87 cents per share reported for fiscal 2010.
Over the past one year, the stock surged around 56%. In comparison Medtronic (MDT), St. Jude Medical (STJ), Boston Scientific (BSX), Thoratec (THOR), and Volcano (VOLC) returned around -13%, 11%, -19%, -4% and 35%, respectively.
All the eight analysts covering the stock recommend buying and expect the stock to gain around 20% over the next 12 months with a consensus target price of $51.5.